China Non Current Liabilities Total from 2010 to 2024

CJJD Stock  USD 1.98  0.13  7.03%   
China Jo's Non Current Liabilities Total is increasing over the years with slightly volatile fluctuation. Non Current Liabilities Total is expected to dwindle to about 4.9 M. During the period from 2010 to 2024 China Jo Non Current Liabilities Total annual values regression line had geometric mean of  729,527 and mean square error of 38.3 T. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2008-12-31
Previous Quarter
6.4 M
Current Value
6.4 M
Quarterly Volatility
6.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check China Jo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China Jo's main balance sheet or income statement drivers, such as Interest Expense of 12.9 K, Other Operating Expenses of 97.3 M or EBITDA of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0288, Dividend Yield of 0.0 or PTB Ratio of 392. China financial statements analysis is a perfect complement when working with China Jo Valuation or Volatility modules.
  
Check out the analysis of China Jo Correlation against competitors.

Latest China Jo's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of China Jo Jo Drugstores over the last few years. It is China Jo's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in China Jo's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

China Non Current Liabilities Total Regression Statistics

Arithmetic Mean4,735,398
Geometric Mean729,527
Coefficient Of Variation150.05
Mean Deviation5,352,935
Median547,183
Standard Deviation7,105,276
Sample Variance50.5T
Range23.3M
R-Value0.54
Mean Square Error38.3T
R-Squared0.30
Significance0.04
Slope865,046
Total Sum of Squares706.8T

China Non Current Liabilities Total History

20244.9 M
20236.4 M
20227.8 M
20219.2 M
202017 M
201923.3 M
2018547.2 K

About China Jo Financial Statements

China Jo stakeholders use historical fundamental indicators, such as China Jo's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although China Jo investors may analyze each financial statement separately, they are all interrelated. For example, changes in China Jo's assets and liabilities are reflected in the revenues and expenses on China Jo's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China Jo Jo Drugstores. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Total6.4 M4.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:
Check out the analysis of China Jo Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.93)
Revenue Per Share
107.003
Quarterly Revenue Growth
(0)
Return On Assets
(0.02)
Return On Equity
(0.27)
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.